Becton Dickinson & Co.
- BDX · NYSE
- Surgical & Medical Instruments & Apparatus
- Franklin Lakes, NJ
- 72,000 employees
- CIK 0000010795
Updated from SEC filings through
Top things to know
Executives
- Thomas E. Polen Jr Chairman, CEO and President 4, 2026-08-14
- Vitor Roque EVP & Chief Financial Officer 4, 2026-09-03
- Christopher DelOrefice EVP & Chief Financial Officer 4, 2025-12-01
- Christopher J. DelOrefice Executive Vice President and Chief Financial Officer 10-K, 2025-11-25
- Michael Feld EVP, Chief Revenue Officer 4, 2026-09-29
- Roland Goette EVP and President, EMEA 4, 2026-08-12
Becton Dickinson & Co is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Franklin Lakes, NJ. It trades as BDX on NYSE. Revenue was $21.8B in the fiscal year ending September 30, 2025, +8.2% from the year before. It reported about 72,000 employees. Thomas E. Polen Jr is Chairman, CEO and President.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.8B 10-K, 2025-11-25 | $20.2B 10-K, 2025-11-25 | $19.4B 10-K, 2025-11-25 | $18.9B 10-K, 2024-11-27 | $19.1B 10-K, 2023-11-21 |
| Operating income | $2.6B 10-K, 2025-11-25 | $2.4B 10-K, 2025-11-25 | $2.1B 10-K, 2025-11-25 | $2.3B 10-K, 2024-11-27 | $2.3B 10-K, 2023-11-21 |
| SG&A | $5.3B 10-K, 2025-11-25 | $4.9B 10-K, 2025-11-25 | $4.7B 10-K, 2025-11-25 | $4.7B 10-K, 2024-11-27 | $4.7B 10-K, 2023-11-21 |
| Net income | $1.7B 10-K, 2025-11-25 | $1.7B 10-K, 2025-11-25 | $1.5B 10-K, 2025-11-25 | $1.8B 10-K, 2024-11-27 | $2.1B 10-K, 2023-11-21 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Thomas E. Polen Jr | Chairman, CEO and President | 4, 2026-08-14 |
| Bertram L. Scott | Board member (per proxy) bio: Former Chief Executive Officer, Affinity Health Plan | DEF 14A, 2025-12-18 |
| Christopher Jones | Board member (per proxy) bio: Former Chief Executive Officer, JWT Worldwide | DEF 14A, 2025-12-18 |
| Gregory J. Hayes | Board member (per proxy) bio: Former Executive Chairman and Chief Executive Officer, RTX Corporation | DEF 14A, 2025-12-18 |
| R. Andrew Eckert | Board member (per proxy) bio: Former Chief Executive Officer, Zelis Inc. | DEF 14A, 2025-12-18 |
| Timothy M. Ring | Board member (per proxy) bio: Former Chairman and Chief Executive Officer, C. R. Bard, Inc. | DEF 14A, 2025-12-18 |
| William M. Brown | Board member (per proxy) bio: Chairman and Chief Executive Officer, 3M Company | DEF 14A, 2025-12-18 |
| Vitor Roque SVP Finance, Business Units & Corp. FP&A | EVP & Chief Financial Officer | 4, 2026-09-03 |
| Jeffrey W. Henderson | Board member (per proxy) bio: Former Chief Financial Officer, Cardinal Health Inc. | DEF 14A, 2025-12-18 |
| Christopher DelOrefice | EVP & Chief Financial Officer | 4, 2025-12-01 |
| Christopher J. DelOrefice | Executive Vice President and Chief Financial Officer | 10-K, 2025-11-25 |
| Michael Feld | EVP, Chief Revenue Officer | 4, 2026-09-29 |
| Roland Goette | EVP and President, EMEA | 4, 2026-08-12 |
| Bilal Muhsin Executive Vice President and President of Connected Care Segment | EVP & President Connected Care | 4, 2026-07-06 |
| Manish Sinha EVP and Chief People Officer at BD | EVP and Chief People Officer | 3, 2026-06-22 |
| Peter Menziuso Executive Vice President and President, Interventional Segment @ BD | EVP and President, BDI | 4, 2026-06-02 |
What Becton Dickinson & Co does
Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context.
Item 1. Business, 10-K for the year ending September 30, 2025
Shares and governance
| Shares outstanding | 272.4 million (as of June 30, 2026) | 10-Q, August 6, 2026 |
|---|---|---|
| Public float | $65.5B (as of March 31, 2025) | 10-K, November 25, 2025 |
| Reportable segments | 4 (period ending June 30, 2026) | 10-Q, August 6, 2026 |
| Latest proxy statement | Meeting December 12, 2025 (filed December 18, 2025) | DEF 14A, December 18, 2025 |
| Auditor | Ernst & Young LLP (New York, New York) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| November 5, 2026 | Thomas E. Polen Jr Chairman, CEO and President | Sale | 2,993 | $629K | Form 4, November 9, 2026 |
| October 26, 2026 | Michael Feld EVP, Chief Revenue Officer | Sale | 76 | $15K | Form 4, October 27, 2026 |
| September 28, 2026 | Michael Feld EVP, Chief Revenue Officer | Sale | 76 | $14K | Form 4, September 29, 2026 |
| August 26, 2026 | Michael Feld EVP, Chief Revenue Officer | Sale | 165 | $31K | Form 4, August 27, 2026 |
| August 13, 2026 | Thomas E. Polen Jr Chairman, CEO and President | Sale | 4,152 | $768K | Form 4, August 14, 2026 |
| August 11, 2026 | Roland Goette EVP and President, EMEA | Sale | 2,438 | $441K | Form 4, August 12, 2026 |
| July 27, 2026 | Michael Feld EVP, Chief Revenue Officer | Sale | 75 | $12K | Form 4, July 28, 2026 |
| June 26, 2026 | Michael Feld EVP, Chief Revenue Officer | Sale | 75 | $11K | Form 4, June 26, 2026 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-22
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-29
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-20
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-05-12
- Item 8.01 Other events
- 8-K filed 2026-05-07
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-29
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-04-09
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-04-02
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Becton Dickinson & Co
- What does Becton Dickinson & Co do?
- In its own words, from Item 1 of its 10-K: "Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context."
- What is Becton Dickinson & Co's revenue?
- $21.8B for the fiscal year ending September 30, 2025, from its 10-K filed November 25, 2025.
- Is Becton Dickinson & Co profitable?
- Becton Dickinson & Co reported net income of $1.7B for the fiscal year ending September 30, 2025.
- How many employees does Becton Dickinson & Co have?
- About 72,000 as of September 30, 2025, as stated in its annual report.
- Who is the CEO of Becton Dickinson & Co?
- Thomas E. Polen Jr, Chairman, CEO and President, as named in a 4 filed August 14, 2026.
- Who is the CFO of Becton Dickinson & Co?
- Vitor Roque, EVP & Chief Financial Officer, as named in a 4 filed September 3, 2026.
- Where is Becton Dickinson & Co headquartered?
- Franklin Lakes, NJ.
- What is Becton Dickinson & Co's stock ticker?
- BDX on NYSE.
- What industry is Becton Dickinson & Co in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Becton Dickinson & Co's website?
- bd.com. Investor relations: https://investors.bd.com/.
- When does Becton Dickinson & Co report earnings next?
- February 4, 2027. Source: estimate_8k_pattern.
- Is Becton Dickinson & Co a public company?
- Yes. Becton Dickinson & Co files with the SEC under CIK 0000010795 and trades as BDX.
- Who audits Becton Dickinson & Co?
- Ernst & Young LLP, New York, New York, as named in its latest annual report (10-K).
- How many shares of Becton Dickinson & Co are outstanding?
- 272.4 million shares as of June 30, 2026, from its 10-Q filed August 6, 2026.
- What is Becton Dickinson & Co's public float?
- $65.5B as of March 31, 2025, as reported on the cover of its 10-K filed November 25, 2025.
- How many business segments does Becton Dickinson & Co report?
- 4 reportable segments for the period ending June 30, 2026, from its 10-Q filed August 6, 2026.
- When is Becton Dickinson & Co's annual shareholder meeting?
- December 12, 2025, per its proxy statement (DEF 14A) filed December 18, 2025.
- Have Becton Dickinson & Co insiders traded stock recently?
- Since July 18, 2025, officers and directors reported 28 open-market sales worth about $4.0M and 1 purchase worth about $1.0M on Forms 4 and 5. The most recent: Thomas E. Polen Jr (Chairman, CEO and President) sold 2,993 shares on November 5, 2026.